In 2025, the FDA approved 73 first-time generic drugs.
Here are the generics and their indication, in order of approval date:
Note: The FDA’s information is current as of Dec. 18.
1. Phytonadione injection — For select coagulation disorders.
2. Esomeprazole magnesium for suspension — For short-term treatment of erosive esophagitis.
3. Regorafenib tablet — For metastatic colorectal cancer.
4. Mesna tablet — For reducing incidence of ifosfamide-induced hemorrhagic cystitis.
5. Ephedrine sulfate injection — For clinically important hypotension occurring in the setting of anesthesia.
6. Eltrombopag olamine tablet — For select cases of thrombocytopenia.
7. Azilsartan medoxomil and chlorthalidone tablet — For hypertension.
8. Nimodipine solution — For reducing the incidence and severity of ischemic deficits in select cases of subarachnoid hemorrhage.
9. Ivermectin tablet — For treatment of intestinal strongyloidiasis.
10. Bosentan tablet for suspension — For pulmonary arterial hypertension.
11. Epinephrine injection — For increasing mean arterial blood pressure in adults with hypotension associated with septic shock.
12. Selenious acid injection — For patients as a source of selenium for parenteral nutrition.
13. Gadoteridol injection — For magnetic resonance imaging.
14. Phenylephrine hydrochloride injection — For clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.
15. Mercaptopurine suspension — For acute lymphoblastic leukemia.
16. Rivaroxaban tablet — For reducing the risk of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation.
17. Pralatrexate injection — For relapsed or refractory peripheral T-cell lymphoma.
18. Fludeoxyglucose F-18 injection — For abnormal glucose metabolism to assist in evaluation of malignancy.
19. Buspirone hydrochloride capsule — For anxiety disorders.
20. Eluxadoline tablet — For irritable bowel syndrome with diarrhea.
21. Bimatoprost drop — For reducing elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.
22. Apalutamide tablet — For metastatic castration-sensative prostate cancer and non-metastatic castration-resistant prostate cancer.
23. Lidocaine patch — For relief of pain association with post-herpetic neuralgia.
24. Technetium TC-99M pentetate acid kit injection — For brain imaging.
25. Acetaminophen injection — For mild to moderate pain management.
26. Nitroglycerin ointment — For preventing angina pectoris due to coronary artery disease.
27. Siponimod tablet — For relapsing forms of multiple sclerosis in adults.
28. Tolvaptan tablet — For slowing kidney function decline in select adults.
29. Naloxone hydrochloride nasal spray — For emergency treatment of opioid overdose.
30. Pilocarpine hydrochloride solution/drop — For presbyopia.
31. Latanoprostene bunod solution/drop — For reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
32. Midazolam in 0.8% sodium chloride injection — For sedation.
33. Halobetasol propionate and tazarotene lotion — For plaque psoriasis.
34. Raltegravir potassium tablet — For treatment of human immunodeficiency virus (HIV-1) infection.
35. Emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablet — For treatment of HIV-1 infection.
36. Perampanel tablet — For partial-onset seizures.
37. Bosutinib monohydrate tablet — For chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia.
38. Magnesium sulfate injection — For replacement therapy in magnesium deficiency.
39. Methylnaltrexone bromide injection — For opioid-induced constipation in adults with chronic non-cancer pain.
40. Angiotensin II acetate injection — For increasing blood pressure in adults with septic or other distributive shock.
41. Sitagliptin and metformin extended-release tablet — For improving glycemic control in adults with Type 2 diabetes.
42. Selenious acid injection — For adult and pediatric patients as a source of selenium for parenteral nutrition.
43. Dehydrated alcohol injection — For inducing controlled cardiac septal infarction to improve exercise capacity in select adults with symptomatic hypertrophic obstructive cardiomyopathy.
44. Meropenem powder for injection — For bacterial meningitis.
45. Rivaroxaban granule for suspension — For reducing the risk of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation.
46. Loteprednol etabonate gel — For treating postoperative inflammation and pain following ocular surgery.
47. Manganese chloride injection — For adult patients as a supplement to intravenous solutions given for TPN.
48. Perampanel suspension — For treatment of partial-onset seizures.
49. Sertraline hydrochloride capsule — For major depressive disorder.
50. Darunavir tablet — For HIV-1 infection.
51. Tazarotene lotion — For acne vulgaris.
52. Ascorbic acid injection — For short-term treatment of scurvy.
53. Baricitinib tablet — For moderately to severely active rheumatoid arthritis.
54. Iron sucrose injection — For treatment of iron deficiency anemia in patients with chronic kidney disease.
55. Cangrelor powder for injection — For reducing the risk of periprocedural myocardial infarction, repeat coronary revascularization, and stent thrombosis in select patients.
56. Norepinephrine bitartrate in 5% dextrose injection — For raising blood pressure in adults with severe, acute hypotension.
57. Liraglutide injection — For weight reduction in patients with obesity or those with at least one weight-related comorbid condition and overweight.
58. Pazopanib hydrochloride tablet — For advanced renal cell carcinoma.
59. Ketamine hydrochloride injection — For diagnostic and surgical procedures that do not require skeletal muscle relaxation.
60. Progesterone vaginal insert — For supporting embryo implantation and early pregnancy.
61. Gallium Ga 68 edotreotide injection — For use with positron emission tomography.
62. Dalbavancin hydrochloride powder for injection — For treatment of acute bacterial skin and skin structure infections caused by select microorganisms.
63. Lomustine capsule — For treatment of primary and metastatic brain tumors.
64. Drospirenone and estradiol tablet — For moderate to severe vasomotor symptoms.
65. Axitinib tablet — For treatment of advanced renal cell carcinoma.
66. Ciprofloxacin hydrochloride and hydrocortisone suspension/drop — For acute otitis externa.
67. Diroximel fumarate delayed-release capsule — For relapsing forms of multiple sclerosis.
68. Iohexol injection — For myelography and computerized tomography myelography.
69. Diazepam rectal gel delivery system — For acute treatment of intermittent, stereotypic episodes of frequent seizure activity.
70. Voriconazole injection — For treatment of invasive aspergillosis.
71. Cladribine tablet — For relapsing forms of multiple sclerosis.
72. Sitagliptin and metformin hydrochloride tablet — For improving glycemic control in adults with Type 2 diabetes.
73. Estradiol vaginal insert — For moderate to severe dyspareunia due to menopause.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
